Towards chemotherapy-free treatment of Philadelphia chromosome-positive acute lymphoblastic leukaemia

被引：0
作者：
Boer, Judith M. [1 ]
van der Sluis, Inge M. [1 ]
机构：
[1] Princess Maxima Ctr Pediat Oncol, NL-3584 CS Utrecht, Netherlands
来源：
LANCET HAEMATOLOGY | 2023年 / 10卷 / 01期
关键词：
IMATINIB; INTERGROUP;
D O I：
10.1016/S2352-3026(22)00351-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E3 / E5
页数：3
相关论文
共 10 条
  • [1] Imatinib treatment of paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (EsPhALL2010): a prospective, intergroup, open-label, single-arm clinical trial
    Biondi, Andrea
    Gandemer, Virginie
    De Lorenzo, Paola
    Cario, Gunnar
    Campbell, Myriam
    Castor, Anders
    Pieters, Rob
    Baruchel, Andre
    Vora, Ajay
    Leoni, Veronica
    Stary, Jan
    Escherich, Gabriele
    Li, Chi-Kong
    Cazzaniga, Giovanni
    Cave, Helene
    Bradtke, Jutta
    Conter, Valentino
    Saha, Vaskar
    Schrappe, Martin
    Valsecchi, Maria Grazia
    [J]. LANCET HAEMATOLOGY, 2018, 5 (12): : E641 - E652
  • [2] Predictive value of minimal residual disease in Philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologies
    Cazzaniga, Giovanni
    De Lorenzo, Paola
    Alten, Julia
    Roettgers, Silja
    Hancock, Jeremy
    Saha, Vaskar
    Castor, Anders
    Madsen, Hans O.
    Gandemer, Virginie
    Cave, Helene
    Leoni, Veronica
    Koehler, Rolf
    Ferrari, Giulia M.
    Bleckmann, Kirsten
    Pieters, Rob
    van der Velden, Vincent
    Stary, Jan
    Zuna, Jan
    Escherich, Gabriele
    zur Stadt, Udo
    Arico, Maurizio
    Conter, Valentino
    Schrappe, Martin
    Valsecchi, Maria Grazia
    Biondi, Andrea
    [J]. HAEMATOLOGICA, 2018, 103 (01) : 107 - 115
  • [3] Final report of a phase II study of imatinib mesylate with hyper-CVAD for the front-line treatment of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia
    Daver, Naval
    Thomas, Deborah
    Ravandi, Farhad
    Cortes, Jorge
    Garris, Rebecca
    Jabbour, Elias
    Garcia-Manero, Guillermo
    Borthakur, Gautam
    Kadia, Tapan
    Rytting, Michael
    Konopleva, Marina
    Kantarjian, Hagop
    O'Brien, Susan
    [J]. HAEMATOLOGICA, 2015, 100 (05) : 653 - 661
  • [4] Dasatinib-Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in Adults
    Foa, Robin
    Bassan, Renato
    Vitale, Antonella
    Elia, Loredana
    Piciocchi, Alfonso
    Puzzolo, Maria-Cristina
    Canichella, Martina
    Viero, Piera
    Ferrara, Felicetto
    Lunghi, Monia
    Fabbiano, Francesco
    Bonifacio, Massimiliano
    Fracchiolla, Nicola
    Di Bartolomeo, Paolo
    Mancino, Alessandra
    De Propris, Maria-Stefania
    Vignetti, Marco
    Guarini, Anna
    Rambaldi, Alessandro
    Chiaretti, Sabina
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (17) : 1613 - 1623
  • [5] Ponatinib and blinatumomab for Philadelphia chromosome- positive acute lymphoblastic leukaemia: a US, single-centre, single-arm, phase 2 trial
    Jabbour, Elias
    Short, Nicholas J.
    Jain, Nitin
    Huang, Xuelin
    Montalban-Bravo, Guillermo
    Banerjee, Pinaki
    Rezvani, Katayoun
    Jiang, Xianli
    Kim, Kun Hee
    Kanagal-Shamanna, Rashmi
    Khoury, Joseph D.
    Patel, Keyur
    Kadia, Tapan M.
    Daver, Naval
    Chien, Kelly
    Alvarado, Yesid
    Garcia-Manero, Guillermo
    Issa, Ghayas C.
    Haddad, Fadi G.
    Kwari, Monica
    Thankachan, Jennifer
    Delumpa, Ricardo
    Macaron, Walid
    Garris, Rebecca
    Konopleva, Marina
    Ravandi, Farhad
    Kantarjian, Hagop
    [J]. LANCET HAEMATOLOGY, 2023, 10 (01): : e24 - e34
  • [6] Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
    Roberts, K. G.
    Li, Y.
    Payne-Turner, D.
    Harvey, R. C.
    Yang, Y-L.
    Pei, D.
    McCastlain, K.
    Ding, L.
    Lu, C.
    Song, G.
    Ma, J.
    Becksfort, J.
    Rusch, M.
    Chen, S-C.
    Easton, J.
    Cheng, J.
    Boggs, K.
    Santiago-Morales, N.
    Iacobucci, I.
    Fulton, R. S.
    Wen, J.
    Valentine, M.
    Cheng, C.
    Paugh, S. W.
    Devidas, M.
    Chen, I-M.
    Reshmi, S.
    Smith, A.
    Hedlund, E.
    Gupta, P.
    Nagahawatte, P.
    Wu, G.
    Chen, X.
    Yergeau, D.
    Vadodaria, B.
    Mulder, H.
    Winick, N. J.
    Larsen, E. C.
    Carroll, W. L.
    Heerema, N. A.
    Carroll, A. J.
    Grayson, G.
    Tasian, S. K.
    Moore, A. S.
    Keller, F.
    Frei-Jones, M.
    Whitlock, J. A.
    Raetz, E. A.
    White, D. L.
    Hughes, T. P.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (11) : 1005 - 1015
  • [7] Dasatinib and low-intensity chemotherapy in elderly patients with Philadelphia chromosome-positive ALL
    Rousselot, Philippe
    Coude, Marie Magdelaine
    Gokbuget, Nicola
    Passerini, Carlo Gambacorti
    Hayette, Sandrine
    Cayuela, Jean-Michel
    Huguet, Francoise
    Leguay, Thibaut
    Chevallier, Patrice
    Salanoubat, Celia
    Bonmati, Caroline
    Alexis, Magda
    Hunault, Mathilde
    Glaisner, Sylvie
    Agape, Philippe
    Berthou, Christian
    Jourdan, Eric
    Fernandes, Jose
    Sutton, Laurent
    Banos, Anne
    Reman, Oumedaly
    Lioure, Bruno
    Thomas, Xavier
    Ifrah, Norbert
    Lafage-Pochitaloff, Marina
    Bornand, Anne
    Morisset, Laure
    Robin, Valerie
    Pfeifer, Heike
    Delannoy, Andre
    Ribera, Josep
    Bassan, Renato
    Delord, Marc
    Hoelzer, Dieter
    Dombret, Herve
    Ottmann, Oliver G.
    [J]. BLOOD, 2016, 128 (06) : 774 - 782
  • [8] Hyper-CVAD Plus Ponatinib Versus Hyper-CVAD Plus Dasatinib as Frontline Therapy for Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Propensity Score Analysis
    Sasaki, Koji
    Jabbour, Elias J.
    Ravandi, Farhad
    Short, Nicholas J.
    Thomas, Deborah A.
    Garcia-Manero, Guillermo
    Daver, Naval G.
    Kadia, Tapan M.
    Konopleva, Marina Y.
    Jain, Nitin
    Issa, Ghayas C.
    Jeanis, Vicki
    Moore, Haim G.
    Garris, Rebecca S.
    Pemmaraju, Naveen
    Cortes, Jorge E.
    O'Brien, Susan M.
    Kantarjian, Hagop M.
    [J]. CANCER, 2016, 122 (23) : 3650 - 3656
  • [9] Impact of complete molecular response on survival in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia
    Short, Nicholas J.
    Jabbour, Elias
    Sasaki, Koji
    Patel, Keyur
    O'Brien, Susan M.
    Cortes, Jorge E.
    Garris, Rebecca
    Issa, Ghayas C.
    Garcia-Manero, Guillermo
    Luthra, Rajyalakshmi
    Thomas, Deborah
    Kantarjian, Hagop
    Ravandi, Farhad
    [J]. BLOOD, 2016, 128 (04) : 504 - 507
  • [10] Efficacy of tyrosine kinase inhibitors in Ph-like acute lymphoblastic leukemia harboring ABL-class rearrangements
    Tanasi, Ilaria
    Ba, Ibrahima
    Sirvent, Nicolas
    Braun, Thorsten
    Cuccuini, Wendy
    Ballerini, Paola
    Duployez, Nicolas
    Tanguy-Schmidt, Aline
    Tamburini, Jerome
    Maury, Sebastien
    Dore, Eric
    Himberlin, Chantal
    Duclos, Cedric
    Chevallier, Patrice
    Rousselot, Philippe
    Bonifacio, Massimiliano
    Cave, Helene
    Baruchel, Andre
    Dombret, Herve
    Soulier, Jean
    Landman-Parker, Judith
    Boissel, Nicolas
    Clappier, Emmanuelle
    [J]. BLOOD, 2019, 134 (16) : 1351 - 1355
1